Life-threatening bleeding episodes among American newborns have risen markedly over the past decade as more parents decline routine medical interventions at birth. According to two major clinical studies released in November 2026, an accelerating drop in prophylactic care has exposed thousands of newborns to preventable hemorrhages. Nationwide, newborn vitamin K refusals more than doubled between 2017 and 2025, climbing steadily from an uncommon clinical exception into an expanding trend that pediatric researchers say carries severe consequences for early childhood survival.
Providing an intramuscular vitamin K injection within hours of delivery has served as the universal standard of newborn care across American hospitals since 1961. The practice was established because infants are naturally born with deficient reserves of the vitamin, which the human liver relies on to produce essential blood-clotting factors. Without sufficient supplementation, infants remain uniquely susceptible to vitamin K deficiency bleeding, an internal hemorrhagic disorder that can occur spontaneously without warning or trauma. For generations, adherence to the preventative injection remained routine among delivery wards. By 2017, however, medical records showed an initial national refusal rate of 3.1 percent. That opt-out rate grew to 5.1 percent by the end of 2024 and reached 6.8 percent in 2025.
Epidemiologists tracking the trend note that foregoing the birth injection places infants at immediate physical risk. Babies who miss the single shot experience a 47 percent higher risk of suffering a serious bleeding event during their first six months of life compared with infants who receive it. Even more dangerous is the specific threat of intracranial hemorrhage. Research indicates that infants who do not receive the medication face more than double the risk of bleeding inside the brain, a crisis that frequently results in permanent brain damage or fatal outcomes.
## Medical Records Show Steep Rise in Deficiency Bleeding
The medical evidence comes from two large observational studies analyzing millions of infant health charts, with research published in JAMA and JAMA Pediatrics. One extensive investigation, directed by Virginia Commonwealth University epidemiologist Dr. Steven Woolf, examined records from 11 million infants aged six months and younger between 2017 and 2025. Over that eight-year window, Dr. Woolf’s team cataloged 5,217 separate bleeding episodes across the nationwide cohort.
The data revealed a direct connection between falling vaccination coverage and clinical complications. Between 2017 and 2025, the overall percentage of infants in the study population receiving vitamin K injections dropped from 97.7 percent to 95 percent. During that same timeframe, the national incidence of vitamin K deficiency bleeding nearly quadrupled. The deterioration accelerated most rapidly toward the end of the survey period, with bleeding rates recorded in 2025 roughly doubling those documented just twelve months earlier in 2024.
To capture the clinical weight of missed preventative care, the researchers calculated population risk ratios. The analysis established that one additional infant bleeding episode develops for every 114 newborns who miss their post-birth vitamin K injection. Dr. Woolf observed that departing from established standards of pediatric care is generating measurable physical harm among young patients.
A parallel study led by Dr. Kristan Scott of the Children’s Hospital of Philadelphia corroborated the trend by reviewing records from 5.2 million infants delivered between 2017 and 2025. Dr. Scott’s team recorded the same baseline shift, finding that national opt-out rates rose from 3.1 percent to 6.8 percent and documenting the corresponding 47 percent increase in infant bleeding complications. While NBC News reported that Dr. Scott’s findings appeared in JAMA, reporting from tippinsights attributed that specific paper to JAMA Pediatrics.
## Ongoing Opt-Out Trends and Shifting Parental Hesitancy
Parental declinations did not level off at the end of the 2025 evaluation period. A subsequent review conducted by the healthcare data firm Truveta for Reuters analyzed more than 1 million birth records through the early months of 2026. The figures revealed that parental refusals rose by more than 57 percent between January and June 2026 alone, demonstrating that resistance to the newborn injection has continued to gather momentum.
Physicians working in delivery wards and neonatal units report treating the acute physical fallout of these decisions. Pediatrician Dr. Thomas Patterson recounted caring for infants who suffered severe brain hemorrhages following their parents’ choice to decline standard vitamin K injections at birth.
Public health researchers attribute the growing reluctance to a mix of online misinformation and an erosion of trust in medical guidance. Reporting from tippinsights noted that part of the hesitance stems from confusion regarding Food and Drug Administration black box warnings. Pediatric clinicians note that the broader dynamic extends beyond a single preventative treatment. Dr. Elizabeth Wolf, a pediatrician at the Children’s Hospital of Richmond at VCU, observed that the rising declination rates closely parallel recent community measles outbreaks, describing both situations as tangible symptoms of deepening public skepticism toward healthcare institutions and clinical experts.
## Surveillance Gaps and Legislative Inquiries
As bleeding incidents rise, public health advocates and lawmakers have voiced concern over the lack of centralized data collection. Currently, the Centers for Disease Control and Prevention does not track nationwide rates of newborn vitamin K refusals, nor does the agency maintain an active surveillance program to document infant bleeding events linked to nutritional deficiencies.
The absence of systematic data tracking led to formal congressional inquiries in the summer of 2026. Representative Kim Schrier, a Democrat from Washington, joined Senator Angela Alsobrooks, a Democrat from Maryland, in calling upon the Centers for Disease Control and Prevention to begin logging infant bleeding cases nationwide so that clinicians and policymakers can evaluate the full scope of the emergency.
Federal health agencies have not committed to establishing a tracking registry. A spokesperson for the Department of Health and Human Services confirmed that the Centers for Disease Control and Prevention continues to endorse the standard newborn injection, but the representative declined to comment on whether the department intends to roll out federal tracking systems for future refusals or deficiency cases.
The debate over routine newborn care coincides with significant leadership shifts and legal disputes surrounding federal public health guidelines. Health Secretary Robert F. Kennedy Jr. moved to rescind formal childhood recommendations for six routine vaccines, a directive that remains suspended under active federal court challenges. In the absence of an overarching federal surveillance registry, medical researchers emphasize that the total nationwide death toll resulting from infant vitamin K deficiency bleeding remains officially uncounted.
